Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Current Assets (2020 - 2025)

Rani Therapeutics Holdings (RANI) has 6 years of Current Assets data on record, last reported at $5.0 million in Q3 2025.

  • For Q3 2025, Current Assets fell 84.69% year-over-year to $5.0 million; the TTM value through Sep 2025 reached $5.0 million, down 84.69%, while the annual FY2024 figure was $29.7 million, 41.5% down from the prior year.
  • Current Assets reached $5.0 million in Q3 2025 per RANI's latest filing, down from $11.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $132.4 million in Q3 2021 and bottomed at $5.0 million in Q3 2025.
  • Average Current Assets over 5 years is $65.5 million, with a median of $66.4 million recorded in 2021.
  • Peak YoY movement for Current Assets: soared 59.58% in 2021, then crashed 84.69% in 2025.
  • A 5-year view of Current Assets shows it stood at $119.6 million in 2021, then dropped by 15.61% to $100.9 million in 2022, then plummeted by 49.62% to $50.8 million in 2023, then plummeted by 41.5% to $29.7 million in 2024, then plummeted by 83.34% to $5.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $5.0 million in Q3 2025, $11.1 million in Q2 2025, and $17.8 million in Q1 2025.